Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",41865,234,0.96 [0.77-1.20],0.7322109642613494
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43307,325,1.12 [0.95-1.32],0.1762253887803597
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",42875,2274,1.04 [0.97-1.11],0.2337212944459447
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Candidiasis,43348,710,0.97 [0.86-1.11],0.692524580169759
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,42021,5805,1.04 [1.00-1.09],0.0567604405293632
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),42221,5257,1.07 [1.03-1.12],0.0018578718026728
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,42927,1992,0.99 [0.92-1.07],0.8626433802005127
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,43190,144,1.13 [0.89-1.43],0.326372230039213
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39964,1568,1.03 [0.95-1.12],0.4182505125204712
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38560,1755,1.09 [1.01-1.17],0.0208876964820621
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,38448,417,0.94 [0.79-1.12],0.4827051185326196
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,30438,3240,1.06 [1.01-1.12],0.0295735066963452
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38199,638,1.16 [1.04-1.30],0.0080494801112426
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,43277,2342,1.01 [0.95-1.09],0.665628173302825
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Mycoses,43475,837,1.01 [0.91-1.13],0.8199094561417584
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,42120,1519,1.07 [0.99-1.15],0.1097784368595862
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,43363,1732,1.04 [0.96-1.12],0.3723630574896801
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41262,327,1.11 [0.95-1.31],0.193511635289617
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,43563,75,1.24 [0.94-1.65],0.1286548401659111
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other septicaemia,43144,1513,1.03 [0.95-1.12],0.4679411360340617
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,43172,126,1.15 [0.89-1.48],0.2953215869200176
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43417,261,1.16 [0.97-1.38],0.1005631743799412
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43389,233,1.21 [1.01-1.44],0.0380156060707644
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41277,676,1.03 [0.91-1.16],0.6741946380893151
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,41053,452,1.02 [0.87-1.19],0.8207397565113265
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,41098,163,1.10 [0.88-1.39],0.3956284270014862
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,43522,90,1.14 [0.85-1.54],0.3834246159511101
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43449,264,0.98 [0.79-1.20],0.8229161516079533
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral warts,43273,88,0.96 [0.67-1.38],0.8338818586372619
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],43299,114,0.98 [0.71-1.34],0.8817688101350523
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm,43070,493,0.97 [0.83-1.13],0.7134253061659339
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43415,99,1.06 [0.77-1.45],0.7383978459809624
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43377,108,1.19 [0.91-1.54],0.2035117874772624
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19977,106,0.72 [0.48-1.07],0.1029407787055554
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",43002,2407,1.02 [0.96-1.09],0.5023370640979763
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of meninges,43538,96,1.14 [0.85-1.53],0.3705387174045097
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43450,113,1.13 [0.86-1.48],0.3729758169750246
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,43521,170,1.30 [1.09-1.56],0.0042619587204919
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of ovary,23480,148,0.84 [0.62-1.14],0.2661313168540165
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Ascending colon,43519,615,0.95 [0.82-1.09],0.4386603965937973
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Caecum,43531,500,1.09 [0.95-1.25],0.2072935134794374
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43372,118,1.21 [0.96-1.54],0.1080424392691097
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Descending colon,43521,370,0.88 [0.73-1.07],0.2078874368177773
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Rectum,43447,590,0.87 [0.74-1.01],0.0649268676996818
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43364,1053,0.99 [0.89-1.09],0.7990600987225371
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Transverse colon,43514,714,1.14 [1.03-1.27],0.0133861996966525
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Carcinoma in situ of breast,19054,119,0.81 [0.57-1.15],0.2428575880922644
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19126,138,0.81 [0.59-1.12],0.2025062051457737
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",34720,90,1.03 [0.73-1.45],0.8616900752073235
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",34745,115,0.86 [0.61-1.22],0.4067668489591948
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43470,204,0.92 [0.72-1.18],0.503569137010949
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Haemangioma, any site",43471,199,0.91 [0.71-1.17],0.4692260789182527
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Leiomyoma of uterus,22685,498,0.98 [0.85-1.14],0.7838949089998319
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Lung cancer and mesothelioma,30266,581,1.06 [0.92-1.22],0.4306111790974447
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Lymphoid leukaemia,34720,90,1.08 [0.78-1.49],0.6601802180826316
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34944,314,1.19 [1.02-1.38],0.02462890910829
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",34963,333,0.96 [0.80-1.16],0.6745319644043
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19251,160,1.04 [0.81-1.34],0.7424149482816406
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",34769,139,1.04 [0.79-1.36],0.785299354448149
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",34799,169,0.90 [0.68-1.19],0.4637751327321699
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",34801,171,1.11 [0.89-1.38],0.3644205226956939
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19220,129,1.16 [0.91-1.49],0.2394804331022406
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",34785,155,1.18 [0.94-1.46],0.1461906673219365
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16684,1145,0.96 [0.87-1.06],0.4341789847110919
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",34823,193,1.02 [0.81-1.29],0.8404010522003621
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",34754,124,1.13 [0.87-1.46],0.3737510305888925
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,34803,173,1.11 [0.89-1.39],0.3502801127379079
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanocytic naevi,43233,342,1.05 [0.88-1.24],0.6021958879706096
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanocytic naevi of trunk,43497,151,1.03 [0.79-1.34],0.84018372918704
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanoma in situ,34686,135,1.19 [0.95-1.49],0.1271770777654022
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",34784,154,0.99 [0.76-1.30],0.937124523367472
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34892,262,1.09 [0.90-1.31],0.3751408036197793
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",35030,400,0.94 [0.79-1.11],0.4384144949142656
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",34791,161,1.21 [0.98-1.49],0.0801037382726273
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Other benign neoplasms of skin,43256,274,1.25 [1.07-1.45],0.0044746996863224
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",36428,1798,1.04 [0.96-1.12],0.3458515265760652
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",36523,1893,1.05 [0.97-1.13],0.2175204520560372
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,43065,582,1.01 [0.88-1.16],0.9015530279216613
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,40433,148,0.81 [0.59-1.11],0.1806665215997604
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,42609,126,1.15 [0.89-1.48],0.2923876503486449
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,42266,4796,1.07 [1.02-1.12],0.0024735180474831
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,41169,77,1.11 [0.81-1.54],0.5116082742909729
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,42874,85,1.34 [1.06-1.70],0.015863035272923
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,42777,2492,1.04 [0.98-1.11],0.1984458830760257
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,42775,2490,1.04 [0.98-1.11],0.1973943853441218
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,40427,142,1.14 [0.90-1.44],0.2692621081514744
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,43028,1936,1.10 [1.03-1.18],0.0050281239274799
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,42981,192,1.16 [0.94-1.42],0.1603091597504053
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,42586,103,1.34 [1.06-1.68],0.0126537322456648
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,42589,106,1.06 [0.79-1.44],0.6904594180392376
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,43241,452,0.96 [0.82-1.13],0.6472684857919682
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,43390,91,1.04 [0.74-1.46],0.8103390756384965
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",43167,378,0.90 [0.74-1.08],0.2549500698645132
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,41266,174,0.81 [0.61-1.08],0.1511898791595872
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,33810,502,1.14 [1.00-1.30],0.0508322471170006
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,40606,190,1.16 [0.94-1.43],0.1683368998397627
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,40631,215,1.18 [0.97-1.42],0.097750084914994
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,33400,92,1.08 [0.79-1.49],0.6201845571893417
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,40480,107,1.19 [0.92-1.54],0.184454624576342
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,39549,383,0.95 [0.80-1.14],0.6066269811901666
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",42800,883,1.02 [0.92-1.13],0.6999822260904985
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,42365,448,0.92 [0.77-1.08],0.2993025933042328
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,42097,180,0.99 [0.77-1.27],0.9133452929437282
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,42986,2613,1.08 [1.02-1.15],0.0115917728327236
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,38048,2542,1.08 [1.02-1.15],0.0140980547070439
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",33410,102,0.73 [0.49-1.09],0.1222715071852569
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",40251,135,0.94 [0.70-1.27],0.7016224024385589
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,33759,451,1.20 [1.06-1.37],0.0039704308350742
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,33409,101,1.25 [0.97-1.60],0.0845979421049514
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,39220,5912,1.08 [1.04-1.13],6.498441080699068e-05
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,33646,338,1.02 [0.86-1.22],0.7929727312616048
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,34229,921,1.12 [1.02-1.24],0.0187372897134305
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43432,525,1.13 [1.00-1.29],0.0496118332858588
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,43117,210,1.29 [1.09-1.52],0.002617064118116
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,33526,218,1.19 [0.99-1.43],0.070602894892173
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",33411,103,1.29 [1.02-1.64],0.0337899674409354
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,42659,2543,1.07 [1.00-1.14],0.0362785500484612
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,33723,415,1.17 [1.03-1.34],0.0141999609382091
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,33761,453,1.07 [0.92-1.24],0.3916439832234579
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34366,1058,1.08 [0.98-1.19],0.1201390209110813
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,33487,179,0.98 [0.76-1.27],0.8982105960602641
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,43106,199,1.28 [1.08-1.52],0.0042563222789024
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,34316,1008,1.05 [0.96-1.16],0.2982402873210241
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,34119,811,1.09 [0.99-1.21],0.0938658238826089
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,39276,110,1.18 [0.91-1.54],0.2143748455574706
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41650,8342,1.07 [1.03-1.10],0.0001365691674326
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,40191,75,0.86 [0.57-1.32],0.5029248336155868
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,40211,95,1.20 [0.91-1.58],0.1998288974002212
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,43256,3246,0.98 [0.92-1.04],0.535809897171715
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",43257,3241,0.98 [0.92-1.04],0.4829307746439503
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,40202,86,1.15 [0.84-1.56],0.379957521276289
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,42990,2027,1.07 [1.00-1.14],0.0580139707705237
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",35909,2601,1.07 [1.01-1.14],0.0203823648656816
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,43545,348,1.05 [0.89-1.24],0.589004822293136
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,42038,121,0.97 [0.71-1.32],0.82471771218809
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,41140,177,1.15 [0.93-1.42],0.2048312739800568
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,41203,240,1.08 [0.89-1.32],0.4410110806095776
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",33578,270,1.23 [1.05-1.44],0.0109778941517768
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39651,263,1.15 [0.97-1.37],0.1071113809102989
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,3584,138,0.80 [0.57-1.12],0.1937042988584476
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,3819,418,1.07 [0.92-1.26],0.3780877334660663
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,39492,104,1.17 [0.90-1.53],0.2498936358261677
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,3526,81,0.94 [0.63-1.41],0.782377898230811
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,42513,3125,1.02 [0.96-1.08],0.4995236767385399
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,42472,555,0.83 [0.71-0.98],0.0256221760569778
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,39771,605,1.10 [0.98-1.24],0.1187730853236363
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34546,1238,1.07 [0.98-1.17],0.1094992460907941
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43370,410,0.93 [0.78-1.10],0.3956476356226696
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),41687,271,1.16 [0.97-1.38],0.0944939650653156
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Angina pectoris,39843,1986,1.00 [0.93-1.08],0.9987497979516796
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Aortic aneurysm,41817,401,1.05 [0.90-1.24],0.5311934233518856
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,41514,98,1.30 [1.01-1.66],0.0397776741604972
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",41746,330,1.14 [0.97-1.34],0.1214846081027446
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,26981,3107,0.97 [0.91-1.03],0.346250039648947
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,AV-block,36831,705,1.02 [0.90-1.15],0.7837950131911944
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43461,690,0.97 [0.86-1.11],0.6856666129765449
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cardiac arrest,24184,310,1.22 [1.04-1.44],0.0125629366206793
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36410,284,0.98 [0.79-1.20],0.813809449440413
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",36284,158,0.92 [0.69-1.22],0.5647969944785006
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,43559,74,1.08 [0.77-1.51],0.6605246842460354
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Conduction disorders,37860,1734,1.04 [0.96-1.13],0.3247877612185824
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,41296,3471,1.01 [0.96-1.07],0.665540842044854
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,38117,12789,1.04 [1.01-1.07],0.0048751100632014
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41260,444,0.92 [0.78-1.09],0.3591323054149187
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Endocarditis,36244,118,1.05 [0.78-1.41],0.7546062894864454
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Heart failure, strict",43213,1817,1.04 [0.96-1.12],0.3343840384567538
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypertension,39659,10949,1.05 [1.01-1.08],0.0036036436017145
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, essential",39672,10962,1.05 [1.01-1.08],0.0037460613143754
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, portal",43264,133,1.20 [0.96-1.50],0.1137217188082206
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29025,315,1.12 [0.94-1.33],0.1898080720617011
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28876,166,0.95 [0.72-1.26],0.7339973992997186
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypotension,43322,1899,1.08 [1.01-1.16],0.0305011481092222
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,42044,172,0.75 [0.56-1.02],0.0688142303815617
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",41603,3746,1.01 [0.96-1.06],0.7490824005783377
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",42952,929,1.06 [0.96-1.18],0.2221631159228932
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Left bundle-branch block,36731,605,1.03 [0.90-1.18],0.6658049544979932
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42787,1404,1.05 [0.97-1.14],0.2437372702193082
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39042,1185,1.09 [1.00-1.19],0.0512254112073367
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43403,268,1.08 [0.90-1.30],0.3878403523300143
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",43512,523,1.02 [0.88-1.17],0.7902533788430919
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Oesophageal varices,40903,87,1.10 [0.80-1.51],0.5597978376117271
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other aneurysm,41543,127,0.96 [0.71-1.31],0.8115332499676583
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other arrhythmias,36836,710,1.12 [1.00-1.25],0.0561614863493731
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,41585,169,1.47 [1.26-1.70],4.52236657592861e-07
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41810,394,1.09 [0.94-1.28],0.2583638509512634
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,36426,300,0.95 [0.78-1.17],0.6339429285426567
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other disorders of veins,40965,149,1.02 [0.78-1.33],0.9004056265593712
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,40899,83,1.01 [0.71-1.45],0.9494921197389994
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,41214,104,0.89 [0.62-1.27],0.5101873296567966
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,41035,219,0.99 [0.78-1.24],0.9123985514031624
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37811,1685,1.07 [0.99-1.16],0.0800515534724705
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,41513,90,1.10 [0.80-1.52],0.5400100403052814
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42314,898,1.09 [0.99-1.21],0.0891530194601617
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42529,587,1.04 [0.92-1.19],0.5141106924142953
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",42106,996,1.00 [0.90-1.11],0.9906059937272108
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24425,551,1.04 [0.90-1.20],0.5851982238367931
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Peripheral artery disease,42031,666,1.16 [1.04-1.30],0.0077795686140115
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41391,575,0.92 [0.79-1.06],0.2519219862525811
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Pulmonary embolism,42726,784,1.03 [0.92-1.15],0.6569654753691953
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43437,1074,1.06 [0.97-1.17],0.2032973038464905
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Right bundle-branch block,36699,573,1.05 [0.92-1.21],0.4490992315009832
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Secondary right heart disease,42521,579,1.04 [0.92-1.19],0.5037037685710581
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,41420,310,0.95 [0.78-1.16],0.6395865228498963
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",42929,1057,1.03 [0.93-1.13],0.5629489040218854
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",42893,1121,1.03 [0.93-1.13],0.5854170788757812
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,41995,95,0.95 [0.67-1.36],0.7937332586585548
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,41547,132,0.87 [0.63-1.21],0.4154941447488891
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Transient ischemic attack,42394,371,1.09 [0.93-1.27],0.3084232248368911
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41809,426,1.06 [0.91-1.23],0.4485775859074525
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Varicose veins,41512,696,1.04 [0.92-1.18],0.506017803839852
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,41440,141,0.91 [0.67-1.24],0.556761814654712
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Venous thromboembolism,43175,1236,0.97 [0.88-1.07],0.5480112567203775
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43353,601,1.03 [0.90-1.17],0.6510533096112275
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",38164,2385,1.09 [1.02-1.16],0.0082099851876882
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Any mental disorder,42472,6693,1.02 [0.98-1.06],0.2582906944768938
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43276,704,1.04 [0.92-1.17],0.5655089148167913
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",38440,2661,1.08 [1.02-1.15],0.0105497510734637
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35919,140,1.15 [0.91-1.46],0.232261157303823
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Smoking dependency,42655,2319,1.04 [0.97-1.11],0.2873254305233484
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",38532,2753,1.02 [0.96-1.08],0.5948033553406964
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Vascular dementia,42764,210,0.84 [0.65-1.09],0.1818193891721009
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Alzheimer disease,43561,559,0.86 [0.74-1.01],0.060077784859678
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",29532,94,0.80 [0.54-1.20],0.2836151729337978
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Bell's palsy,40577,135,0.85 [0.61-1.17],0.3138126724936417
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41282,840,0.98 [0.87-1.10],0.6815655299340768
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Cerebral cysts,42883,369,1.06 [0.90-1.25],0.4557506898427199
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43422,516,0.90 [0.77-1.05],0.1788961345083659
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,42744,94,0.84 [0.57-1.24],0.3717993443376189
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,43534,109,1.02 [0.75-1.39],0.8895996456693385
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",42629,115,0.97 [0.71-1.33],0.8493769015112138
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Epilepsy,40974,474,1.02 [0.87-1.18],0.8391083834654274
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42753,2253,1.01 [0.95-1.09],0.6862399565468208
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,43486,703,0.91 [0.79-1.04],0.1557778044596025
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Falls/tendency to fall,42573,4253,1.01 [0.97-1.07],0.5694336580542307
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Generalized epilepsy,42935,93,1.25 [0.97-1.62],0.0877796684977257
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Hemiplegia,43314,408,0.90 [0.75-1.07],0.2293028581961336
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Hydrocephalus,42616,102,1.24 [0.97-1.58],0.0916692706789926
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,43529,118,1.20 [0.94-1.53],0.1384314102281662
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,40571,129,0.76 [0.54-1.07],0.1138448685770911
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,40572,130,0.90 [0.66-1.24],0.529784916067084
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Memory loss,42521,194,1.00 [0.79-1.27],0.9696595014897348
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Migraine,41097,597,1.03 [0.90-1.18],0.6522366125841583
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43442,542,1.05 [0.92-1.20],0.4740763528484512
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Motor neuron disease,29731,256,1.07 [0.88-1.30],0.492715330689329
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43265,183,0.83 [0.63-1.09],0.1823392117289128
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42443,2001,0.96 [0.89-1.04],0.3418854226571012
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Neurological diseases,41051,6108,0.98 [0.94-1.02],0.3089729287960208
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,42960,310,0.98 [0.81-1.19],0.8407917217987363
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",41113,671,1.02 [0.90-1.15],0.7768080845189562
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",43431,485,1.04 [0.90-1.20],0.5752781981507475
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34864,1077,0.93 [0.83-1.03],0.1679781321449122
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,42633,119,1.00 [0.74-1.36],0.9808242716322806
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other disorders of nervous system,42749,235,0.94 [0.75-1.18],0.5882948290463759
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,43031,248,0.91 [0.73-1.14],0.4102024671469781
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other facial nerve disorders,40602,160,0.84 [0.63-1.14],0.2661098201624582
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other headache syndromes,40597,97,1.07 [0.78-1.47],0.6943078658144066
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other neurological diseases,43364,850,1.07 [0.97-1.19],0.1941517307409102
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other sleep disorders,41427,927,1.00 [0.90-1.12],0.9931273243295468
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Parkinson's disease,43517,414,0.88 [0.74-1.06],0.1770761396062802
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,42605,91,1.15 [0.85-1.55],0.3782584093788289
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Restless leg syndrome,43559,111,0.91 [0.65-1.27],0.5824283135831165
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Sleep apnoea,43160,803,0.99 [0.88-1.12],0.9265878479144448
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Small fibre neuropathy,43028,82,1.24 [0.94-1.63],0.1302496129241566
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,43533,300,1.00 [0.83-1.21],0.9910699897016372
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,40527,85,0.74 [0.48-1.14],0.1769392343476759
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,43561,565,0.89 [0.77-1.04],0.1343781808778331
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),42697,203,0.82 [0.63-1.07],0.1463787387451932
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,42611,159,0.83 [0.61-1.12],0.2195201046369465
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,42883,655,1.02 [0.90-1.16],0.7666277295048072
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43286,391,1.05 [0.90-1.24],0.510943232170602
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,41856,91,0.97 [0.68-1.38],0.8595560805314238
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41867,102,1.11 [0.83-1.50],0.4770326480407627
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",43377,86,1.08 [0.78-1.50],0.632114783430968
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,43128,244,0.98 [0.79-1.22],0.8555576399358791
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",3532,86,1.00 [0.69-1.46],0.9800462198453822
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4276,160,0.92 [0.69-1.22],0.5515664073296358
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,42616,164,1.17 [0.94-1.45],0.15517426901916
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,43221,1738,1.06 [0.99-1.15],0.1050076162411694
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42934,1169,1.05 [0.96-1.15],0.3128065011509843
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42143,378,1.11 [0.95-1.29],0.1940273694637471
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43424,1196,0.99 [0.90-1.09],0.899056022934861
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,43548,117,1.15 [0.88-1.49],0.3007791338863471
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,43305,1077,1.01 [0.91-1.11],0.879209416156634
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",43492,608,1.01 [0.89-1.15],0.8578954603832959
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,43402,305,1.09 [0.92-1.30],0.315170681447783
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,41867,102,1.07 [0.79-1.44],0.6774816486126909
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,41878,113,1.01 [0.75-1.37],0.9339994416171872
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,41862,97,1.16 [0.88-1.54],0.2861969445019074
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43402,1183,0.99 [0.90-1.09],0.8608147486576193
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,42530,311,0.81 [0.65-1.01],0.0648677113109914
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,42307,79,0.72 [0.46-1.14],0.1602526658612681
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,43052,168,1.04 [0.82-1.33],0.7296790056292055
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,43339,455,1.00 [0.86-1.17],0.9793831790720452
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,42553,325,1.10 [0.93-1.29],0.2683347844385504
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,43280,183,0.97 [0.75-1.25],0.8071134383542302
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42991,772,1.03 [0.92-1.16],0.5909666396671982
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,42682,230,1.05 [0.85-1.29],0.653199160402467
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,40886,3677,1.04 [0.99-1.10],0.109419388921276
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,43280,396,1.04 [0.89-1.22],0.6019417942135065
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,43526,255,1.14 [0.95-1.36],0.1539251950807085
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42458,693,1.05 [0.93-1.18],0.4420698381158269
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,43001,117,0.95 [0.69-1.31],0.7576979375804114
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,43524,93,1.23 [0.94-1.59],0.129499539547921
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,41906,141,1.01 [0.77-1.33],0.9496344950815336
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,42020,255,1.07 [0.88-1.30],0.499144155987248
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,41674,191,1.08 [0.87-1.34],0.502516569102806
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,42323,95,0.81 [0.55-1.20],0.2948293420987787
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",41593,110,0.78 [0.54-1.14],0.1976821820107448
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,42362,143,1.04 [0.80-1.35],0.7731397148707664
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",42542,323,0.93 [0.77-1.13],0.4623119444879922
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,41970,205,1.17 [0.96-1.41],0.1126349037964365
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,41667,184,1.16 [0.94-1.43],0.1644698536749763
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,41616,133,0.85 [0.61-1.18],0.3284306409197151
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,40201,2992,0.99 [0.93-1.05],0.7608089117927631
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,41887,122,1.12 [0.86-1.46],0.3977132588774826
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,43135,683,1.06 [0.94-1.19],0.375319192818293
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,42549,97,1.07 [0.78-1.45],0.6818609741914643
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),42721,269,1.04 [0.86-1.26],0.693020763315265
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,43188,149,0.92 [0.68-1.22],0.5502167863541726
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,43485,200,0.83 [0.64-1.09],0.1792902407450309
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,43342,217,1.11 [0.91-1.36],0.3044024440017644
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,43145,106,1.09 [0.81-1.45],0.5790570316246
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,43152,113,0.95 [0.69-1.32],0.7610562583698683
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,43386,1472,1.07 [0.99-1.16],0.1090835344881997
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,42961,1047,1.07 [0.98-1.18],0.1462076461858263
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,42125,211,0.97 [0.76-1.22],0.7719864564211478
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,42055,141,1.40 [1.18-1.66],0.0001337578161326
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute pharyngitis,43131,117,0.88 [0.63-1.24],0.4697838440845255
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43380,366,0.93 [0.77-1.12],0.4267028670006035
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,43125,111,0.97 [0.71-1.34],0.8752307185617483
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,All influenza,40243,193,1.04 [0.84-1.31],0.7009073183951422
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),40239,189,1.07 [0.86-1.33],0.5620587006386968
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Allergic asthma (mode),29887,202,1.01 [0.80-1.27],0.9225416672471928
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Allergic rhinitis,43353,476,1.05 [0.91-1.21],0.5260063148138532
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",32251,3017,1.08 [1.02-1.14],0.0083210610744343
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",32654,2969,1.08 [1.02-1.14],0.0062939158626392
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),42876,234,1.17 [0.98-1.40],0.0783913421246744
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",40184,134,1.20 [0.95-1.51],0.1188358495097347
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Bronchiectasis,37708,585,1.08 [0.96-1.23],0.2089639706672239
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",37219,96,1.10 [0.81-1.50],0.5279408479595272
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,41845,4722,1.06 [1.02-1.11],0.0066108731402513
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",41226,124,0.93 [0.68-1.27],0.6474122584157043
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Chronic sinusitis,41356,254,1.04 [0.86-1.27],0.674077014295427
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",43226,1982,1.04 [0.97-1.12],0.2780617907122841
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Deviated nasal septum,41291,189,0.97 [0.76-1.25],0.8297037571422947
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40055,8787,1.03 [1.00-1.07],0.0571432241062625
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41731,629,1.02 [0.90-1.16],0.7736056932347041
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Early onset COPD,41787,543,1.05 [0.91-1.20],0.5086703520451636
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Emphysema,37653,530,1.14 [1.00-1.29],0.0497510119689882
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41307,502,1.04 [0.91-1.20],0.5447442109370586
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Influenza and pneumonia,43175,3125,1.03 [0.97-1.09],0.3866633080296267
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Interstitial lung disease,41364,559,1.05 [0.92-1.20],0.4513859329284103
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Later onset COPD,41844,1439,1.04 [0.96-1.13],0.3719073121880204
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,43538,509,0.98 [0.84-1.13],0.7661393601962959
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Nasal polyp,41289,187,1.00 [0.78-1.27],0.9971615483072668
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,43127,1601,0.98 [0.90-1.07],0.6844591202436442
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other diseases of pleura,43158,3316,1.08 [1.03-1.14],0.0038544948655885
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42527,1425,1.05 [0.97-1.14],0.2520123046008413
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other pleural conditions,39929,87,0.84 [0.56-1.25],0.3916027981581297
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43396,690,1.05 [0.93-1.18],0.4456652559463417
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,43373,2172,1.11 [1.04-1.18],0.0020001988626464
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pleural effusion,41468,1626,1.07 [1.00-1.16],0.0623838747555886
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pleural plaque,40111,269,1.01 [0.83-1.23],0.9107981425017512
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",42755,2705,1.02 [0.96-1.08],0.5612230742823847
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,43429,400,1.01 [0.86-1.19],0.8977260327734551
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pneumothorax,40046,204,1.12 [0.91-1.37],0.2762285581286197
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pollen allergy,43522,407,1.05 [0.90-1.23],0.5203736356296238
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pulmonary oedema,42815,109,1.12 [0.85-1.47],0.4219347964827512
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Respiratory insufficiency,29777,92,1.13 [0.83-1.53],0.4415696000455403
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,43091,1565,0.98 [0.90-1.06],0.6022101100511463
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,41579,477,1.05 [0.91-1.22],0.5042830320936885
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Viral pneumonia,40453,403,1.00 [0.85-1.18],0.9988859204101548
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",42903,333,0.96 [0.80-1.16],0.6856190448863365
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20131,187,1.16 [0.93-1.44],0.2014789036225199
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30878,109,0.99 [0.71-1.37],0.9376316352581346
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute appendicitis,43282,239,0.81 [0.64-1.04],0.1016799229229244
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute gastritis,32840,145,1.00 [0.76-1.32],0.9851345755996104
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute pancreatitis,40468,313,1.07 [0.90-1.27],0.4630524254794048
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute peritonitis,42771,149,1.27 [1.05-1.55],0.0158729280227674
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Alcoholic liver disease,42069,125,1.06 [0.81-1.41],0.6603629205738728
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Barrett oesophagus,33417,722,0.99 [0.87-1.12],0.8798383962799792
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",40323,168,1.19 [0.97-1.45],0.0926433458719182
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",42870,168,1.19 [0.97-1.46],0.0899307750924357
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Cholecystitis,40487,332,1.09 [0.93-1.28],0.2984046253086437
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Cholelithiasis,41870,1715,1.00 [0.92-1.08],0.9884242325607696
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Chronic gastritis,33204,509,0.97 [0.83-1.12],0.6526529698255579
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Chronic pancreatitis,40237,82,0.71 [0.45-1.11],0.1292660848210433
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",43316,185,0.94 [0.72-1.21],0.6247507146982164
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Coeliac disease,40875,198,1.38 [1.18-1.60],3.369174553071211e-05
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Collagenous colitis,40733,131,0.87 [0.63-1.20],0.3877517888859486
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43296,322,0.89 [0.72-1.09],0.2519147971283855
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Constipation,43126,2741,1.01 [0.95-1.08],0.6630756884240959
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Crohn disease,40744,142,0.91 [0.68-1.23],0.5493754783549774
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42970,102,0.96 [0.69-1.35],0.8262873571820005
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40736,134,0.90 [0.66-1.22],0.490048885639518
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Dental caries,42314,385,1.06 [0.90-1.25],0.4602815339535874
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,39106,3702,1.06 [1.00-1.11],0.0364537174706129
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of appendix,43345,302,0.87 [0.71-1.08],0.2007631184756964
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of liver,43357,1413,1.04 [0.96-1.13],0.3348438830456439
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",39895,7200,1.05 [1.01-1.09],0.0129173057006795
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42853,924,1.07 [0.96-1.18],0.2254090892892959
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43412,790,1.05 [0.94-1.18],0.3717551519161987
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,42114,185,0.98 [0.76-1.25],0.8573064793035385
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of salivary glands,41876,102,1.16 [0.87-1.53],0.3167216617311699
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of the digestive system,43045,2368,1.03 [0.96-1.10],0.4617528106608994
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of tongue,41893,183,1.09 [0.87-1.37],0.440881263818506
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42538,2383,1.02 [0.95-1.09],0.5552581447760774
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36076,5307,1.02 [0.98-1.07],0.279762241711177
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Duodenal ulcer,33025,330,1.11 [0.94-1.30],0.2193961304997853
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43406,261,1.10 [0.91-1.32],0.3348351105169181
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43418,89,1.17 [0.87-1.58],0.3050577537141544
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,42164,220,0.95 [0.75-1.20],0.6409576577045448
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31020,251,0.87 [0.69-1.10],0.2356230549386329
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Functional dyspepsia,33615,920,1.09 [0.98-1.20],0.109613409175661
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastric ulcer,33304,609,1.06 [0.94-1.21],0.3357751762875364
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,36876,4181,1.06 [1.01-1.11],0.0291445008972858
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33604,909,1.10 [0.99-1.21],0.0636789523754932
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,33726,13886,1.03 [1.00-1.06],0.0414493502907062
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,GI-bleeding,42600,1923,0.97 [0.90-1.05],0.4690974340166463
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,42032,103,1.08 [0.80-1.47],0.6075965312800449
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,32402,2114,0.99 [0.93-1.07],0.8894961952607017
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",42046,102,1.04 [0.76-1.42],0.8024678710439801
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Hernia,40802,5398,1.05 [1.01-1.10],0.0159592612170986
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Impacted teeth,43429,83,1.29 [0.98-1.69],0.066204604093588
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Impaction of intestines,30866,97,1.21 [0.93-1.58],0.1638759999019515
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Inguinal hernia,36914,1510,1.00 [0.92-1.09],0.9218069826243585
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",35574,170,1.01 [0.78-1.30],0.951968316838016
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,30924,155,0.93 [0.70-1.23],0.6236294543045239
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40914,237,1.31 [1.13-1.53],0.0003556850064878
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31693,924,0.99 [0.89-1.10],0.8175157287268692
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,43516,610,1.11 [0.98-1.25],0.0910568277304584
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41861,1259,1.12 [1.03-1.21],0.0085046361568731
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42280,1678,1.08 [1.00-1.16],0.0420163275496576
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32998,303,1.06 [0.89-1.27],0.527400718149281
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oesophagitis,33702,1007,0.93 [0.83-1.04],0.222983523039672
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43474,229,1.03 [0.83-1.27],0.79559742749528
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,35517,113,1.21 [0.94-1.55],0.1374583365110084
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33055,2286,1.01 [0.95-1.08],0.709937325492987
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40620,465,1.04 [0.90-1.20],0.5992898681179006
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,40418,263,0.89 [0.71-1.11],0.2983933668471836
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of intestine,33719,2950,1.02 [0.96-1.08],0.5421386477233816
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of intestines,40171,9402,1.00 [0.97-1.04],0.9170875072898595
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41865,347,1.06 [0.89-1.25],0.5305337357158165
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of liver,43096,1152,1.03 [0.94-1.13],0.5163135298442497
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33800,1105,1.04 [0.94-1.14],0.4238377699147101
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of pancreas,40398,243,0.97 [0.78-1.20],0.7841062062324886
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43303,681,1.00 [0.88-1.14],0.965437825268354
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,34278,1583,1.07 [0.99-1.16],0.0741588999411512
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,42624,1947,0.97 [0.90-1.05],0.4725386328788996
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42222,293,1.10 [0.93-1.31],0.2741056111966669
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,33590,2821,1.01 [0.95-1.08],0.6603451468529595
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),36057,3362,1.06 [1.00-1.12],0.0432450887246847
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,42112,168,1.19 [0.97-1.47],0.097904037680165
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,42076,1474,1.07 [0.99-1.16],0.0834520274528744
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31345,576,1.03 [0.90-1.18],0.6878504726387475
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43399,105,1.10 [0.82-1.48],0.5198139597511574
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31589,820,1.02 [0.91-1.14],0.7447737273982195
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40938,261,1.12 [0.94-1.35],0.2022535016701447
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Recurring oral aphthae,43540,97,0.96 [0.68-1.36],0.8269769963794451
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,41932,196,1.03 [0.82-1.30],0.7765243316623077
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Toxic colitis,40697,95,1.11 [0.82-1.50],0.5107930577784563
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33159,464,1.01 [0.87-1.18],0.8903368724350236
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ulcerative colitis,40872,270,1.13 [0.95-1.35],0.1694735476814964
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40828,226,1.14 [0.94-1.38],0.1762342197939824
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Umbilical hernia,35854,450,0.90 [0.76-1.07],0.2198691228916853
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,31066,297,0.98 [0.81-1.19],0.866499788645761
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ventral hernia,35836,432,1.10 [0.96-1.28],0.1793377009877582
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Volvulus,30902,133,1.14 [0.89-1.46],0.2923131926798723
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,43431,488,1.12 [0.99-1.28],0.0747812569625078
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,43023,136,0.87 [0.64-1.19],0.3860425862387727
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,40175,275,1.04 [0.86-1.26],0.7030053383364772
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42478,1175,0.99 [0.90-1.09],0.8962025264660182
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41600,297,1.03 [0.85-1.24],0.7783249193311799
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,40542,642,1.08 [0.96-1.21],0.2242394893955402
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,43037,463,1.06 [0.91-1.22],0.4502199271171021
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43381,807,1.04 [0.93-1.16],0.504736055831978
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,42656,82,1.25 [0.94-1.65],0.1205831792846212
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,40952,5376,1.01 [0.97-1.06],0.6707342699844039
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42801,741,0.95 [0.84-1.08],0.4272823366569687
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42574,514,0.97 [0.83-1.13],0.6855589193745365
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,42894,1591,1.02 [0.94-1.11],0.6029203246387831
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",43533,91,1.18 [0.88-1.58],0.2633500755296994
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,40011,111,0.99 [0.72-1.36],0.937020390934753
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,42152,92,1.01 [0.72-1.42],0.9373223273192228
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,43019,445,1.06 [0.91-1.23],0.4505755134848503
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40666,766,1.01 [0.90-1.14],0.8469378868126837
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,40010,110,0.80 [0.55-1.16],0.2417120878091299
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,43415,136,1.03 [0.78-1.35],0.8570122465765302
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,41598,295,1.18 [1.00-1.38],0.050367364356781
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43212,325,0.83 [0.67-1.02],0.0761784911414673
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,42674,100,1.02 [0.74-1.40],0.9058522714811736
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,40009,109,0.93 [0.66-1.30],0.6625834017285468
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,42602,2702,1.06 [0.99-1.12],0.076134465875008
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40734,834,1.06 [0.95-1.19],0.2616018271307567
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,40017,117,0.89 [0.63-1.25],0.4996171892804101
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43414,527,0.91 [0.78-1.06],0.2280596876625848
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,42694,120,0.83 [0.59-1.17],0.2850314308572159
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43320,433,0.85 [0.71-1.02],0.0800351498914559
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,43474,531,1.09 [0.95-1.24],0.2059722921281537
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,40118,218,1.05 [0.84-1.30],0.6853624905519662
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40341,441,1.05 [0.91-1.23],0.4895108498465668
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,43456,513,1.09 [0.95-1.24],0.214063659328411
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",40279,379,1.19 [1.03-1.37],0.0172124536084995
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,43506,227,0.99 [0.79-1.23],0.9184405725925832
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,37355,186,1.25 [1.03-1.52],0.0219017536128874
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39629,9457,1.04 [1.01-1.07],0.0166281537932937
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37276,7104,1.04 [1.00-1.08],0.0263829146979397
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,37298,129,1.23 [0.97-1.56],0.0916117626648484
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37806,255,1.04 [0.86-1.27],0.667529288087449
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37849,298,0.99 [0.82-1.21],0.946653687746744
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,43140,156,1.05 [0.81-1.35],0.7288120833808662
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",37716,165,0.83 [0.62-1.12],0.2241328866085893
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,32083,1911,1.04 [0.97-1.12],0.2308491596572087
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43323,324,1.03 [0.86-1.23],0.7687675987847475
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38265,714,1.07 [0.95-1.20],0.2481542435015906
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36804,12198,1.04 [1.01-1.07],0.0120678874944887
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40234,207,0.98 [0.77-1.23],0.8381300774814864
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,37425,256,0.94 [0.75-1.17],0.5615327918563475
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,38139,970,1.04 [0.94-1.16],0.4204250962907037
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,41983,4432,1.03 [0.98-1.08],0.1919060702993929
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37634,465,1.01 [0.86-1.18],0.910479088169228
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,37547,378,1.16 [1.01-1.35],0.0421938589646135
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37403,234,1.01 [0.81-1.25],0.9540815979956168
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,42432,121,0.95 [0.70-1.30],0.766503920105006
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,33008,2836,1.03 [0.97-1.10],0.2946031009035581
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31143,971,1.06 [0.96-1.17],0.255535022404749
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43428,956,1.05 [0.95-1.17],0.3030795645239826
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30296,124,0.84 [0.60-1.17],0.3015087361553678
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30735,563,0.93 [0.80-1.08],0.3239487792682151
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37677,508,0.96 [0.83-1.12],0.6262529514397119
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31258,1086,1.11 [1.01-1.21],0.0265654105317604
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,37640,89,1.02 [0.73-1.43],0.9196911483581172
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38605,1054,1.05 [0.96-1.16],0.2895074569000445
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,38054,503,0.99 [0.86-1.15],0.9424466257226942
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31183,1011,1.11 [1.01-1.22],0.0238985239408176
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,37299,130,1.20 [0.94-1.53],0.1405472284472105
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",37269,100,1.17 [0.88-1.56],0.2800335488580242
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,40147,120,1.03 [0.77-1.39],0.8202675888822512
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,42910,2883,1.04 [0.98-1.10],0.2306903496384238
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,41915,1888,1.05 [0.98-1.13],0.1943502568653553
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43317,764,1.05 [0.94-1.17],0.4234853182310916
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,34374,4202,1.04 [0.99-1.09],0.0884679616445603
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,30275,103,0.92 [0.65-1.30],0.640649845848915
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,37322,153,1.14 [0.90-1.45],0.2697783046817512
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,30261,89,1.06 [0.77-1.46],0.717338756587252
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30389,217,1.08 [0.88-1.32],0.4580899485048801
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40440,413,1.03 [0.88-1.21],0.734306376123975
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,40648,621,0.97 [0.84-1.11],0.6380382725817613
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,43509,163,1.35 [1.14-1.60],0.000679592417485
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",40569,3018,1.04 [0.98-1.10],0.214898602378679
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37337,168,0.97 [0.75-1.27],0.8406588000103355
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30411,239,0.81 [0.63-1.04],0.0967113945060584
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38760,1209,0.98 [0.89-1.08],0.7519157384175673
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33791,3619,1.03 [0.97-1.08],0.3084595525700556
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,42469,158,1.05 [0.82-1.35],0.6861271878121808
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,43532,128,0.92 [0.68-1.26],0.6151099805593828
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37305,136,1.00 [0.75-1.33],0.9747053490740348
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",39254,2085,1.08 [1.01-1.15],0.0287525764241731
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,37317,148,1.13 [0.89-1.44],0.3227757073680538
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,32902,2730,1.05 [0.99-1.11],0.1369032145706932
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40224,197,1.01 [0.79-1.27],0.956872607228926
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,37253,84,1.04 [0.73-1.48],0.8381366519818256
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,37817,266,1.00 [0.81-1.22],0.963165488347136
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38084,915,1.04 [0.94-1.16],0.425341071526538
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42919,608,1.12 [1.00-1.26],0.0576398968075327
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38508,957,0.98 [0.87-1.09],0.6621703714261546
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43336,745,1.06 [0.94-1.18],0.3486535085422423
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,43523,90,1.03 [0.74-1.44],0.8414451326864254
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37486,317,0.99 [0.82-1.19],0.8999771994713699
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34481,1251,1.09 [1.00-1.19],0.05940376501772
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,38133,964,1.08 [0.97-1.19],0.1488586676554296
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37554,385,1.04 [0.88-1.23],0.6360312887299611
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",30269,97,1.03 [0.75-1.42],0.8364572759526564
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,34336,4164,1.05 [1.00-1.11],0.0315132894715082
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31268,1096,1.01 [0.91-1.11],0.9072129917233952
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,42698,387,1.03 [0.88-1.22],0.6914721185312738
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",43451,105,1.10 [0.83-1.48],0.5004267703932272
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",39916,83,1.05 [0.74-1.48],0.8001667953400853
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,30303,131,0.91 [0.67-1.25],0.5672202594479896
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,37726,175,1.19 [0.97-1.47],0.0921441425488996
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30946,774,1.05 [0.94-1.18],0.3504026068271874
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37692,523,1.05 [0.91-1.21],0.5077235849635777
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37974,423,1.25 [1.10-1.41],0.0005090062194482
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,37859,308,1.05 [0.88-1.25],0.6007324865870599
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,34063,102,1.00 [0.72-1.39],0.986247057105242
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",43530,97,0.98 [0.70-1.38],0.9283729315753304
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,38162,993,1.06 [0.96-1.17],0.2858042186830111
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],42477,166,1.25 [1.03-1.52],0.0269984642112378
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,41509,4340,1.03 [0.98-1.09],0.192296598661893
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37393,224,0.95 [0.75-1.20],0.6497611495527579
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38429,878,1.06 [0.96-1.18],0.2433934522042464
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,41148,389,0.99 [0.84-1.17],0.93316902254359
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,37876,325,1.17 [1.00-1.36],0.0454130913684886
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,40109,2558,1.04 [0.97-1.10],0.263338204244852
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,39229,1678,1.04 [0.96-1.12],0.328435885410439
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],37256,87,0.95 [0.65-1.38],0.7829364742361054
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42559,248,1.07 [0.88-1.30],0.5016071648524314
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37450,281,1.14 [0.96-1.36],0.1304975195412001
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,37301,132,0.95 [0.71-1.29],0.759366089320817
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),30265,93,0.81 [0.55-1.21],0.3129135535140502
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Acute renal failure,41995,2524,1.08 [1.01-1.15],0.0150404645447246
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17606,86,1.15 [0.85-1.57],0.3607073583605501
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22949,98,0.85 [0.59-1.23],0.3996733232366162
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,43033,531,1.03 [0.89-1.19],0.682547164851302
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,42646,144,0.83 [0.60-1.14],0.2400134411854643
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,41737,2266,1.01 [0.94-1.08],0.7491437787794477
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,43225,106,0.76 [0.52-1.12],0.1655923052087211
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,43195,493,0.87 [0.74-1.03],0.1071924005558778
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Cystitis,38459,388,0.96 [0.81-1.14],0.6430593267385543
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Dialysis,39581,110,1.24 [0.96-1.59],0.0996650001490176
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18954,2747,1.05 [0.99-1.11],0.1161268580494251
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23131,280,0.97 [0.80-1.19],0.7784289092587926
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Endometriosis,17668,148,1.10 [0.86-1.40],0.4487190894353974
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17861,341,0.82 [0.68-1.01],0.0576946915235013
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18383,863,1.06 [0.95-1.17],0.31966039072728
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,36397,8865,1.05 [1.02-1.09],0.0026836003722642
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,43242,123,1.13 [0.87-1.46],0.3716326785881687
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Hydrocele,16376,169,1.13 [0.89-1.42],0.3132326872445833
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,39413,464,0.96 [0.82-1.13],0.6538701108985014
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18373,2166,1.04 [0.97-1.11],0.2868777815744146
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23077,343,1.03 [0.87-1.23],0.6963564141526879
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16401,194,0.78 [0.58-1.03],0.0832385342424503
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Irregular menses,23150,110,0.87 [0.62-1.22],0.4259212911352512
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17787,267,0.87 [0.71-1.08],0.2189024786383012
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38195,124,0.94 [0.69-1.29],0.7061250139037407
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19624,2104,1.02 [0.95-1.09],0.6072404111529436
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16302,95,0.78 [0.51-1.17],0.2254651655633835
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17638,118,1.00 [0.75-1.35],0.9771561636038912
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",43545,110,1.11 [0.84-1.47],0.4678706097188491
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",43545,112,0.78 [0.54-1.13],0.189667180668957
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,41795,3724,1.02 [0.96-1.07],0.5311732621527754
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39271,1200,1.05 [0.96-1.15],0.3110564309860893
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22951,100,1.01 [0.73-1.39],0.9683186062448504
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43453,751,1.02 [0.91-1.15],0.7325061779029372
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16465,258,1.04 [0.84-1.27],0.7273813348581288
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16446,239,1.00 [0.80-1.24],0.9916474710136696
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16396,189,1.01 [0.79-1.28],0.9496737605898128
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,43497,116,1.11 [0.84-1.46],0.4712694437644784
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,40919,2848,1.01 [0.95-1.07],0.8516319418654699
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22912,178,1.07 [0.85-1.34],0.5731910202778747
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17656,136,1.19 [0.94-1.51],0.1422370429841247
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17858,338,1.07 [0.91-1.27],0.3950066489496183
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17621,101,1.02 [0.74-1.41],0.8940452983770986
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17696,176,0.98 [0.76-1.26],0.848201591216051
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39492,543,1.01 [0.87-1.16],0.9443264421929622
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,42944,242,1.06 [0.87-1.29],0.5740053771919184
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17783,263,1.17 [0.99-1.39],0.0712291560786682
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17610,90,1.03 [0.74-1.43],0.8605087129860015
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18073,553,1.06 [0.93-1.21],0.3552930418847331
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17656,136,1.15 [0.90-1.47],0.2681860940147368
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18026,506,0.94 [0.80-1.09],0.410477128422634
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,43205,86,0.85 [0.57-1.27],0.4253110764291452
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16420,213,1.03 [0.83-1.29],0.7635182363788453
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,43201,4252,1.05 [1.00-1.11],0.0330005097266869
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",39152,203,1.01 [0.80-1.27],0.9259387181663832
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39666,195,1.15 [0.94-1.40],0.1845647640598979
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42592,90,0.77 [0.50-1.16],0.2122347978300952
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38448,377,1.10 [0.94-1.28],0.248471141856238
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Urolithiasis,43163,661,0.99 [0.87-1.13],0.8962623319731613
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17638,118,1.24 [0.99-1.56],0.0625461738042668
